Quick View

Dec 15 2012, 01:17 IST
Comments 0
SummaryTaking forward the acquisition process, drug-maker Dr Reddy’s Laboratories said it made a public offer starting Friday to acquire all shares of the Netherlands-based OctoPlus NV, a speciality pharmaceutical company.

Dr Reddy’s public offer for OctoPlus begins

Taking forward the acquisition process, drug-maker Dr Reddy’s Laboratories said it made a public offer starting Friday to acquire all shares of the Netherlands-based OctoPlus NV, a speciality pharmaceutical company. On October 22, the Indian drug major had announced that it had decided to acquire OctoPlus NV for about 27.4 million euro (about R193 crore). “Dr Reddy’s, together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus NV, a service based speciality pharmaceutical company, at an offer price of 0.52 euro (cum-dividend) per share,” DRL said in statement.

BofA ML upgrades cement stocks to ‘buy’

Bank of America-Merrill Lynch on Friday upgraded its rating across cement stocks to ‘buy’ from ‘neutral’ or ‘underperform’, saying capacity will lag demand, while valuations are below previous up cycles. The investment bank added that general elections in the next 18 months bode well for the Indian cement sector given that the demand-GDP multiplier expanded in four out of the five previous election years. Among the major cement manufacturers, BoFA ML upgraded UltraTech Cement and Ambuja Cements to ‘buy’ from ‘underperform’. Among mid-cap stocks, Shree Cement was raised to ‘buy’ from ‘neutral’, while India Cements was upgraded to ‘buy’ from ‘underperform’.

Sensex rally to extend into next year: Poll

The BSE Sensex is expected to climb to a record high by the end of the next year based on expected interest rate cuts and the government's resolve to press on with reforms, a Reuters poll showed. The Sensex has rallied strongly since June, despite an economy headed for its slowest yearly rate of growth in a decade, stubbornly high inflation, and a record current account deficit. The global economic backdrop has also been poor, with growth in many other emerging market economies slowing and tepid demand from the recession-mired euro zone and sluggish US economies. But the median projection of 20 equity analysts in a survey conducted over the past week showed the Sensex is expected to hit 20,500 by June next year, and rally to 22,250 by the end of 2013, surpassing a record high of 21,206.77 from January 2008. The mid-year consensus is almost the same as the one three months ago.

Diageo’s shareholding in USL to go up to 27.4%

The shareholders of United Spirits (USL) have approved the preferential allotment of shares to Diageo Plc, allowing the UK major to take its

Single Page Format
Ads by Google

More from Corporates & Markets

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...